Generated: December 13, 2017
DrugPatentWatch Database Preview
Details for Patent: 8,217,057
« Back to Dashboard
Which drugs does patent 8,217,057 protect, and when does it expire?
Summary for Patent: 8,217,057
|Title:||Polymorphs of a c-MET/HGFR inhibitor|
|Abstract:|| This invention relates to polymorphs of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-py- razol-4-yl)-pyridin-2-ylamine that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to compositions including such salts and polymorphs, and to methods of using such compositions in the treatment of abnormal cell growth in mammals, especially humans.|
|Inventor(s):|| Cui; Jingrong Jean (San Diego, CA), Tran-Dube; Michelle Bich (San Diego, CA) |
|Assignee:|| Pfizer Inc. (New York, NY) |
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Dosage form; |
Foreign Priority and PCT Information for Patent: 8,217,057
|PCT Filed||November 23, 2006||PCT Application Number:||PCT/IB2006/003383|
|PCT Publication Date:||June 14, 2007||PCT Publication Number:||
International Patent Family for Patent: 8,217,057
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.